ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.906,55
-0,32%
S&P 500
5.460,48
-0,41%
US Dollar vs BRL
5,5936
0,00%
Bitcoin
60.936,78
1,04%
Brent Oil
84,85
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Interpace Biosciences Inc (IDXG)

  7. Interpace Biosciences Inc (IDXG) Notícias

IDXG

Interpace Biosciences (IDXG)

Interpace Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IDXG
DataHoraFonteTítuloCódigoCompanhia
12/05/202317:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDXGInterpace Biosciences Inc
12/05/202317:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDXGInterpace Biosciences Inc
03/05/202316:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDXGInterpace Biosciences Inc
28/04/202317:20Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:IDXGInterpace Biosciences Inc
27/03/202317:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDXGInterpace Biosciences Inc
14/11/202218:41GlobeNewswire Inc.Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going ConcernNASDAQ:IDXGInterpace Biosciences Inc
20/10/202217:28GlobeNewswire Inc.Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual MeetingNASDAQ:IDXGInterpace Biosciences Inc
20/09/202217:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDXGInterpace Biosciences Inc
20/09/202217:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDXGInterpace Biosciences Inc
09/09/202217:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IDXGInterpace Biosciences Inc
01/09/202218:18GlobeNewswire Inc.Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly ImprovedNASDAQ:IDXGInterpace Biosciences Inc
31/08/202218:30GlobeNewswire Inc.Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.NASDAQ:IDXGInterpace Biosciences Inc
15/08/202217:05GlobeNewswire Inc.Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly ImprovedNASDAQ:IDXGInterpace Biosciences Inc
16/05/202217:15GlobeNewswire Inc.Interpace Biosciences Announces First Quarter 2022 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
11/05/202209:30GlobeNewswire Inc.Miroculus to Optimize Automated Next Generation Sequencing Library Preparation with Interpace Diagnostics and Twist BioscienceNASDAQ:IDXGInterpace Biosciences Inc
08/04/202207:15TipRanksAnalysts Offer Insights on Healthcare Companies: Interpace Diagnostics Group (OtherIDXG) and Biogen (BIIB)NASDAQ:IDXGInterpace Biosciences Inc
31/03/202217:15GlobeNewswire Inc.Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
22/02/202211:00GlobeNewswire Inc.Interpace Biosciences Announces Update of Previously Announced CMS Billing Policy Impacting its Thyroid TestsNASDAQ:IDXGInterpace Biosciences Inc
02/02/202218:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDXGInterpace Biosciences Inc
01/02/202212:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDXGInterpace Biosciences Inc
28/01/202221:35GlobeNewswire Inc.Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid TestsNASDAQ:IDXGInterpace Biosciences Inc
27/01/202218:05GlobeNewswire Inc.Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New DirectorNASDAQ:IDXGInterpace Biosciences Inc
13/01/202208:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDXGInterpace Biosciences Inc
13/01/202208:05Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:IDXGInterpace Biosciences Inc
12/01/202218:41GlobeNewswire Inc.Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights OfferingNASDAQ:IDXGInterpace Biosciences Inc
03/01/202219:07GlobeNewswire Inc.Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights OfferingNASDAQ:IDXGInterpace Biosciences Inc
10/11/202118:05GlobeNewswire Inc.Interpace Biosciences Announces Third Quarter 2021 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
02/11/202117:15GlobeNewswire Inc.Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity LoansNASDAQ:IDXGInterpace Biosciences Inc
28/10/202109:15GlobeNewswire Inc.Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related ConditionsNASDAQ:IDXGInterpace Biosciences Inc
21/10/202110:15GlobeNewswire Inc.Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid NeoplasmsNASDAQ:IDXGInterpace Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IDXG

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
TELB4
TELEBRAS PN
BOV
PRIO3
PETRORIO ON
BOV
TECN3
TECHNOS ON
BOV
GOLL4
GOL PN
BOV
BMGB4
BMG PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados